PURPOSE: Several studies have described the content of Twitter conversations about lung, breast, and prostate cancer, but little is known about how the public uses Twitter to discuss kidney cancer. We sought to characterize the content of conversations on Twitter about kidney cancer and the participants engaged in these dialogues. METHODS: This qualitative study analyzed the content of 2,097 tweets that contained the key words kidney cancer from August 1 to 22, 2017. Tweets were categorized by content domain of conversations related to kidney cancer on Twitter and user types of participants in these dialogues. RESULTS: Among the 2,097 kidney cancer-related tweets analyzed, 858 (41.4%) were authored by individuals, 865 (41.2%) by organizations, and 364 (17.4%) by media sites. The most common content discussed was support (29.3%) and treatment (26.5%). Among the 2,097 tweets, 825 were unique tweets, and 1,272 were retweets. The most common unique tweets were about clinical trials (23.9%), most often authored by media sites. The most common retweets were about treatment (38.5%), most often authored by organizations. CONCLUSION: Twitter dialogues about kidney cancer are most commonly related to support and treatment. Our findings provide insights that may inform the design of new interventions that use social media as a tool to improve communication of kidney cancer information. Additional efforts are needed to improve our understanding of the value and direct utility of social media in improving kidney cancer care.
PURPOSE: Several studies have described the content of Twitter conversations about lung, breast, and prostate cancer, but little is known about how the public uses Twitter to discuss kidney cancer. We sought to characterize the content of conversations on Twitter about kidney cancer and the participants engaged in these dialogues. METHODS: This qualitative study analyzed the content of 2,097 tweets that contained the key words kidney cancer from August 1 to 22, 2017. Tweets were categorized by content domain of conversations related to kidney cancer on Twitter and user types of participants in these dialogues. RESULTS: Among the 2,097 kidney cancer-related tweets analyzed, 858 (41.4%) were authored by individuals, 865 (41.2%) by organizations, and 364 (17.4%) by media sites. The most common content discussed was support (29.3%) and treatment (26.5%). Among the 2,097 tweets, 825 were unique tweets, and 1,272 were retweets. The most common unique tweets were about clinical trials (23.9%), most often authored by media sites. The most common retweets were about treatment (38.5%), most often authored by organizations. CONCLUSION: Twitter dialogues about kidney cancer are most commonly related to support and treatment. Our findings provide insights that may inform the design of new interventions that use social media as a tool to improve communication of kidney cancer information. Additional efforts are needed to improve our understanding of the value and direct utility of social media in improving kidney cancer care.
Authors: Mina S Sedrak; Don S Dizon; Patricia F Anderson; Michael J Fisch; David L Graham; Matthew S Katz; Jennifer C Kesselheim; Robert S Miller; Michael A Thompson; Audun Utengen; Deanna J Attai Journal: Future Oncol Date: 2017-06-07 Impact factor: 3.404
Authors: Deanna J Attai; Mina S Sedrak; Matthew S Katz; Michael A Thompson; Patricia F Anderson; Jennifer C Kesselheim; Michael J Fisch; David L Graham; Audun Utengen; Claire Johnston; Robert S Miller; Don S Dizon Journal: Future Oncol Date: 2016-03-30 Impact factor: 3.404
Authors: J P Struck; F Siegel; M W Kramer; I Tsaur; A Heidenreich; A Haferkamp; A S Merseburger; J Salem; H Borgmann Journal: World J Urol Date: 2018-03-09 Impact factor: 4.226
Authors: Deanna J Attai; Michael S Cowher; Mohammed Al-Hamadani; Jody M Schoger; Alicia C Staley; Jeffrey Landercasper Journal: J Med Internet Res Date: 2015-07-30 Impact factor: 5.428
Authors: Nayeli A Martinez-Ibarra; Yuly A Remolina-Bonilla; Hector H Buerba-Vieregge; Regina Barragan-Carrillo; Francisco J Castro-Alonso; Samantha Mateos-Corella; Maria T Bourlon Journal: Front Endocrinol (Lausanne) Date: 2022-06-29 Impact factor: 6.055
Authors: Maurice J Berkowitz; Carlie K Thompson; Laura T Zibecchi; Minna K Lee; Elani Streja; Jacob S Berkowitz; Cachet M Wenziger; Jennifer L Baker; Maggie L DiNome; Deanna J Attai Journal: J Cancer Surviv Date: 2020-08-17 Impact factor: 4.062